43rd Annual J.P. Morgan Healthcare Conference

Seaport presents at J.P. Morgan Healthcare Conference 2025

Stifel Healthcare Conference

Seaport presents at Stifel Healthcare Conference 2024

VIEW

Molecular Pharmaceutics

Optimizing Triglyceride Prodrugs of a Model Immunomodulator: Conjugation through the Phenol of Mycophenolic Acid (MPA) Markedly Promotes Lymphatic Drug Transport

VIEW

Nature Metabolism

Mesenteric lymphatic dysfunction promotes insulin resistance and represents a potential treatment target in obesity

VIEW

Frontiers in Pharmacology

Triglyceride-Mimetic Prodrugs of Buprenorphine Enhance Oral Bioavailability via Promotion of Lymphatic Transport

VIEW

International Society for CNS Clinical Trials and Methodology Conference

Clinician-administered assessments and impact on placebo response in recent major depressive disorder (MDD) clinical trials

VIEW

Medicinal & Bioorganic Chemistry Foundation (MBCF) 2025

First-in-human Translation of of a Biomimetic Glyceride Prodrug Platform: Enabling Avoidance of First-pass Metabolism via Lymphatic Absorption

VIEW

American College of Neuropsychopharmacology (ACNP) 2024

SPT-300, a First-in-Class Orally Bioavailable Prodrug of the Neurosteroid Allopregnanolone: Safety, Tolerability, and Clinical Pharmacology in Healthy Volunteers

VIEW

101 Seaport Blvd
Seaport Boston, MA 02210

General info: info@seaporttx.com
Media: publicrelations@seaporttx.com

www.SeaportTx.com
@SeaportTx
LinkedIn

Seaport Therapeutics
101 Seaport Blvd
Seaport Boston, MA 02210

info@seaporttx.com
Privacy Policy
Terms of Use

© 2024 Seaport Therapeutics